9th March 2016
Sofitel Legend Amsterdam The Grand
BioCapital Europe 2016, organised by LSP (Life Sciences Partners) is delighted to announce its 14th consecutive event, taking place on Thursday 14th April 2016 in Amsterdam, The Netherlands. For the 6th year running, the event will be held at the luxurious and historic hotel Sofitel Legend The Grand Amsterdam, the former town hall situated in the heart of Amsterdam.
BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech companies from the Benelux and Europe. Attendance is by invitation only. In 2015, the event attracted 200 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited to attend free of charge to this event.
BioCapital Europe Company of the Year award
Which company had a transformative year in terms of its technology, clinical development, partnering, IPO or M&A activities?
The winner will be announced at the BioCapital Europe conference on April 14th
LSP (Life Sciences Partners) is one of Europe’s leading investors in the health care sector. Over more than 25 years, LSP has built elaborate expertise in establishing and growing health care companies with a positive impact on society. In partnership with inventors and entrepreneurs, LSP contributes to the translation of breakthrough concepts into products that benefit patients. LSP connects investors to inventors with a dual goal: generating an interesting financial return and contributing to the quality of life. LSP has offices in Amsterdam, Munich and Boston and has raised over €750 mln (around $1 bln) in funds.
For more information, please visit the new LSP website: www.lspvc.com